What Know About This Fund’s Pharma Stock Sale Surges
A fund’s big move out of a top-performing pharma stock can puzzle investors. Here’s a clear, practical look at what k...
Understanding when a Roth conversion is worth it depends on taxes, future gains, and penalties. This intro offers scenarios to help you judge timing.
5,775 articlesA fund’s big move out of a top-performing pharma stock can puzzle investors. Here’s a clear, practical look at what k...
Citi raises its eBay price target to $127, boosted by better-than-expected execution and momentum in focused growth c...
A dramatic intraday surge in Plug Power stock highlighted the day’s market mood. This article unpacks the catalysts b...
Brokerage mergers are reshaping the mortgage landscape as Compass International Holdings, Real, and eXp expand their ...
As May 2026 unfolds, smart investors are looking for durable growth in healthcare. Here are three standout names, why...
A routine ethics filing has become a focal point for investors and policymakers. This deep dive explains what the qua...
A notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
Bill Ackman’s Microsoft stake is shifting the AI investing playbook, spotlighting OpenAI ties and geopolitical risk a...
A high-flying biotech spin-off has faced a brutal disconnect between hype and reality. This beaten-down growth stock ...
Gene Smith, the former Ohio State athletic director, has been elected to M/I Homes’ board of directors. The move come...
In 2022, the S&P 500 plunged while a healthcare-focused ETF held its ground better than most. This story examines why...
SpaceX’s IPO filing reveals Elon Musk’s proposed package, a historic grant that vests only if the company reaches a $...